New Health Technologies: A UK Perspective; Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies”
Articles in Press, Accepted Manuscript , Available Online from 09 May 2017
The Conceptualization of Value in the Value Proposition of New Health Technologies; Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies”
Articles in Press, Accepted Manuscript , Available Online from 03 July 2017
Don’t Discount Societal Value in Cost-Effectiveness; Comment on “Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness”
Articles in Press, Accepted Manuscript , Available Online from 14 January 2017
Priority Setting for Universal Health Coverage: We Need to Focus Both on Substance and on Process; Comment on “Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, not Just More Evidence on Cost-Effectiveness”
Articles in Press, Accepted Manuscript , Available Online from 22 January 2017
Health Technology Assessment: Global Advocacy and Local Realities; Comment on “Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness”
Volume 6, Issue 4, April 2017, Page 233-236
Kalipso Chalkidou; Ryan Li; Anthony J. Culyer; Amanda Glassman; Karen J. Hofman; Yot Teerawattananon
Human Rights Discourse in the Sustainable Development Agenda Avoids Obligations and Entitlements; Comment on “Rights Language in the Sustainable Development Agenda: Has Right to Health Discourse and Norms Shaped Health Goals?”
How Can a Global Social Support System Hope to Achieve Fairer Competiveness?; Comment on “A Global Social Support System: What the International Community Could Learn From the United States’ National Basketball Association”